Lawmakers question pharma company's plans to charge $89,000/year for drug widely available abroad for roughly $1,000 https://t.co/NnsJtiV01E pic.twitter.com/RvWugpuXtu — ABC News Politics (@ABCPolitics) February 13, 2017